These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 595112)

  • 1. Risk factors in transmission of non-A, non-B posttransfusion hepatitis. The role of hepatitis B antibody in donor blood.
    Conrad ME; Knodell RG; Bradley EL; Flannery EP; Ginsberg AL
    Transfusion; 1977; 17(6):579-85. PubMed ID: 595112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of HBsAg, anti-HBs, the anti-CMV following the transfusion of blood products.
    Contreras TJ; Lang DJ; Pivacek LE; Valeri CR
    Transfusion; 1979; 19(2):129-36. PubMed ID: 219565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion of hepatitis B immune complex-containing blood in high HBV prevalence populations.
    Simons MJ
    Am J Med Sci; 1975; 270(2):349-54. PubMed ID: 1235477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic evidence of hepatitis A and B virus infections in thalassemia patients: a retrospective study.
    Stevens CE; Silbert JA; Miller DR; Dienstag JL; Purcell RH; Szmuness W
    Transfusion; 1978; 18(3):356-60. PubMed ID: 664004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.
    Hoofnagle JH; Seeff LB; Bales ZB; Zimmerman HJ
    N Engl J Med; 1978 Jun; 298(25):1379-83. PubMed ID: 652005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passively acquired antibody to hepatitis B surface antigen. Pitfall in evaluating immunity to hepatitis B viral infections.
    Devine P; Taswell HF; Moore SB; Gilchrist GS; Jacobson TM
    Arch Pathol Lab Med; 1989 May; 113(5):529-31. PubMed ID: 2712676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity.
    Salawu L; Adegoke AO; Aboderin AO; Huraina HA
    West Afr J Med; 2011; 30(4):292-5. PubMed ID: 22669836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.
    Stevens CE; Aach RD; Hollinger FB; Mosley JW; Szmuness W; Kahn R; Werch J; Edwards V
    Ann Intern Med; 1984 Dec; 101(6):733-8. PubMed ID: 6437308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimate of the risk of post transfusion hepatitis B in Jakarta, Indonesia.
    Mboi N; Olson JG; McGreevy PB; Tan R; Moeslichan S
    Int J Epidemiol; 1981 Dec; 10(4):367-72. PubMed ID: 7327835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, prospective study of posttransfusion hepatitis in Milan.
    Colombo M; Oldani S; Donato MF; Borzio M; Santese R; Roffi L; Viganó P; Cargnel A
    Hepatology; 1987; 7(4):709-12. PubMed ID: 3111967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hbc ag, anti-HBC, and DNA polymerase activity in transfused recipients followed prospectively.
    Hollinger FB; Dressman GR; Fields H; Melnick J
    Am J Med Sci; 1975; 270(2):343-8. PubMed ID: 1235476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-transfusion hepatitis in the Zürich region].
    Frey-Wettstein M; Böhlen-Bodmer A; Bütler R
    Schweiz Med Wochenschr; 1986 Sep; 116(36):1216-21. PubMed ID: 3094143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
    Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
    Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempt to prevent hepatitis by using specific anti-HBs immunoglobulin.
    Couroucé-Pauty AM; Delons S; Soulier JP
    Am J Med Sci; 1975; 270(2):375-83. PubMed ID: 1235479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Va cooperative study of post-transfusion hepatitis, 1969-1974: incidence and characteristics of hepatitis and responsible risk factors.
    Seeff LB; Wright EC; Zimmerman HJ; McCollum RW
    Am J Med Sci; 1975; 270(2):355-62. PubMed ID: 1235478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients.
    Sugg U; Schenzle D; Hess G
    Transfusion; 1988; 28(4):386-8. PubMed ID: 3133848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HBsAg in members of the Yugoslav army -- volunteer blood donors].
    Vajzović A
    Bilt Hematol Transfuz; 1978; 6(3):69-74. PubMed ID: 757671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparenteral transmission of viral hepatitis in Greece.
    Hadziyannis SJ
    Am J Med Sci; 1975; 270(2):313-8. PubMed ID: 1235473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.